https://www.hepcoalition.org/ hepCoalition.org is conceived as a tool to support the development of a global advocacy movement on access to hepatitis C diagnostics, treatment and support for people living with a high risk for HCV in low- and middle-income countries, and particularly for people who use drugs and people living with HIV/HCV. hepCoalition.org is developed by Médecins du Monde and Treatment Action Group. en SPIP - www.spip.net https://hepcoalition.org/local/cache-vignettes/L144xH46/hepcoalition-f0be8.svg?1647194578 https://www.hepcoalition.org/ 46 144 https://hepcoalition.org/en/learn/treatment/article/hcv-specific-cd4-t-cells-are-susceptible-to-hiv-1-and-contribute-to-viral https://hepcoalition.org/en/learn/treatment/article/hcv-specific-cd4-t-cells-are-susceptible-to-hiv-1-and-contribute-to-viral 2026-08-09T19:39:26Z text/html en Ana Balkandjieva <p>Study examines the impact of HCV infection on CD4+ T-cell susceptibility to HIV-1 infection in vitro and reservoir persistence during ART in subjects with chronic HCV infection and uninfected controls.</p> - <a href="https://hepcoalition.org/en/learn/treatment/" rel="directory">Treatment</a> https://hepcoalition.org/en/advocate/advocacy-tools/article/community-engagement-on-hcv-through-storytelling https://hepcoalition.org/en/advocate/advocacy-tools/article/community-engagement-on-hcv-through-storytelling 2026-07-28T18:48:00Z text/html en Ana Balkandjieva Viral hepatitis elimination <p>TAG launches two storyboards featuring personal stories to bring the realities of hepatitis C closer to communities, healthcare providers, and decision-makers.</p> - <a href="https://hepcoalition.org/en/advocate/advocacy-tools/" rel="directory">Advocacy Tools</a> / <a href="https://hepcoalition.org/mot/viral-hepatitis-elimination" rel="tag">Viral hepatitis elimination</a> https://hepcoalition.org/en/advocate/advocacy-tools/article/hepatitis-c-elimination-works-ten-years-of-evidence-from-seven-countries https://hepcoalition.org/en/advocate/advocacy-tools/article/hepatitis-c-elimination-works-ten-years-of-evidence-from-seven-countries 2026-07-28T16:29:58Z text/html en Ana Balkandjieva Viral hepatitis elimination <p>A new report marks ten years of CHAI-supported hepatitis C programs in Cambodia, India, Indonesia, Myanmar, Nigeria, Rwanda, and Vietnam.</p> - <a href="https://hepcoalition.org/en/advocate/advocacy-tools/" rel="directory">Advocacy Tools</a> / <a href="https://hepcoalition.org/mot/viral-hepatitis-elimination" rel="tag">Viral hepatitis elimination</a> https://hepcoalition.org/en/cabs/lat-cab-2021-present/article/test https://hepcoalition.org/en/cabs/lat-cab-2021-present/article/test 2026-06-10T23:16:00Z text/html en Ana Balkandjieva Long-acting technologies <p>LAT CAB reviews the state of treatment research, contributes to research protocols, and engages in the research and development process for long-acting technologies for malaria, HCV, HIV, and LTBI.</p> - <a href="https://hepcoalition.org/en/cabs/lat-cab-2021-present/" rel="directory">LAT CAB (2021-present)</a> / <a href="https://hepcoalition.org/mot/long-acting-technologies" rel="tag">Long-acting technologies</a> https://hepcoalition.org/en/cabs/lat-cab-2021-present/article/tag-and-lat-cab-welcome-indian-patent-office-decision-that-could-expand-access https://hepcoalition.org/en/cabs/lat-cab-2021-present/article/tag-and-lat-cab-welcome-indian-patent-office-decision-that-could-expand-access 2026-05-22T18:44:00Z text/html en Ana Balkandjieva Generic drugs Low- and middle-income countries <p>TAG and the LAT CAB celebrate the Indian Patent Office's decision to NOT grant a patent on the HCV combination treatment glecaprevir/pibrentasvir, aka Mavyret® or Maviret® manufactured by AbbVie.</p> - <a href="https://hepcoalition.org/en/cabs/lat-cab-2021-present/" rel="directory">LAT CAB (2021-present)</a> / <a href="https://hepcoalition.org/mot/generic-drugs" rel="tag">Generic drugs</a>, <a href="https://hepcoalition.org/mot/low-and-middle-income-countries" rel="tag">Low- and middle-income countries</a> https://hepcoalition.org/en/advocate/advocacy-tools/article/global-hepatitis-report-2026 https://hepcoalition.org/en/advocate/advocacy-tools/article/global-hepatitis-report-2026 2026-05-01T22:47:17Z text/html en Ana Balkandjieva World Health Organization Viral hepatitis elimination <p>WHO warns current rates of progress are insufficient to meet all 2030 viral hepatitis elimination targets, underscoring the urgent need to accelerate prevention, testing, and treatment efforts worldwide.</p> - <a href="https://hepcoalition.org/en/advocate/advocacy-tools/" rel="directory">Advocacy Tools</a> / <a href="https://hepcoalition.org/mot/world-health-organization" rel="tag">World Health Organization</a>, <a href="https://hepcoalition.org/mot/viral-hepatitis-elimination" rel="tag">Viral hepatitis elimination</a> https://hepcoalition.org/en/news/partner-news/article/england-hepatitis-c-infections-in-people-who-inject-drugs-continue-to-fall https://hepcoalition.org/en/news/partner-news/article/england-hepatitis-c-infections-in-people-who-inject-drugs-continue-to-fall 2026-04-04T20:51:33Z text/html en Ana Balkandjieva People who use drugs Viral hepatitis elimination <p>New report highlights continued progress in eliminating hepatitis C in England.</p> - <a href="https://hepcoalition.org/en/news/partner-news/" rel="directory">Partner News</a> / <a href="https://hepcoalition.org/mot/people-who-inject-drugs" rel="tag">People who use drugs</a>, <a href="https://hepcoalition.org/mot/viral-hepatitis-elimination" rel="tag">Viral hepatitis elimination</a> https://hepcoalition.org/en/learn/care/article/c-the-change-six-innovations-reshaping-hepatitis-c-testing-and-treatment https://hepcoalition.org/en/learn/care/article/c-the-change-six-innovations-reshaping-hepatitis-c-testing-and-treatment 2026-04-04T20:16:28Z text/html en Ana Balkandjieva HCV high-burden populations <p>Elimination of hepatitis C virus will require moving care beyond clinic walls and into the community spaces where patients live, work, and seek support.</p> - <a href="https://hepcoalition.org/en/learn/care/" rel="directory">Care</a> / <a href="https://hepcoalition.org/mot/hcv-high-burden-populations" rel="tag">HCV high-burden populations</a> https://hepcoalition.org/en/news/partner-news/article/taiwan-s-fight-to-end-hepatitis-c https://hepcoalition.org/en/news/partner-news/article/taiwan-s-fight-to-end-hepatitis-c 2026-04-04T19:54:39Z text/html en Ana Balkandjieva Viral hepatitis elimination <p>The Taiwan Hepatitis C Elimination Report has been submitted to the WHO Western Pacific Regional Office for validation under the PTE Gold Tier for hepatitis C elimination.</p> - <a href="https://hepcoalition.org/en/news/partner-news/" rel="directory">Partner News</a> / <a href="https://hepcoalition.org/mot/viral-hepatitis-elimination" rel="tag">Viral hepatitis elimination</a> https://hepcoalition.org/en/learn/care/article/jails-could-cut-hepatitis-c-infections-nearly-in-half-with-testing-and https://hepcoalition.org/en/learn/care/article/jails-could-cut-hepatitis-c-infections-nearly-in-half-with-testing-and 2026-03-28T23:32:14Z text/html en Ana Balkandjieva People who use drugs Prisons Viral hepatitis elimination <p>Jail-based HCV interventions, especially those offering treatment, significantly enhance HCV elimination in people who inject drugs — and are a cost-effective public health strategy.</p> - <a href="https://hepcoalition.org/en/learn/care/" rel="directory">Care</a> / <a href="https://hepcoalition.org/mot/people-who-inject-drugs" rel="tag">People who use drugs</a>, <a href="https://hepcoalition.org/mot/prisons" rel="tag">Prisons</a>, <a href="https://hepcoalition.org/mot/viral-hepatitis-elimination" rel="tag">Viral hepatitis elimination</a>